Contec Medical Systems Co Ltd
Contec Medical Systems Co.,Ltd engages in the research and development, production, and sale of medical diagnosis and monitoring equipment in China and internationally. The company offers electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, patient monitors, stethoscopes, simulators, multi-parameter vital signs monitors, central monitoring systems, electrocardiograph… Read more
Contec Medical Systems Co Ltd (300869) - Total Assets
Latest total assets as of September 2025: CN¥2.79 Billion CNY
Based on the latest financial reports, Contec Medical Systems Co Ltd (300869) holds total assets worth CN¥2.79 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Contec Medical Systems Co Ltd - Total Assets Trend (2013–2024)
This chart illustrates how Contec Medical Systems Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Contec Medical Systems Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Contec Medical Systems Co Ltd's total assets of CN¥2.79 Billion consist of 70.5% current assets and 29.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 25.1% |
| Accounts Receivable | CN¥53.34 Million | 2.0% |
| Inventory | CN¥272.32 Million | 10.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥52.07 Million | 1.9% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Contec Medical Systems Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Contec Medical Systems Co Ltd's current assets represent 70.5% of total assets in 2024, an increase from 49.5% in 2013.
- Cash Position: Cash and equivalents constituted 25.1% of total assets in 2024, up from 7.6% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 3.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 10.0% of total assets.
Contec Medical Systems Co Ltd Competitors by Total Assets
Key competitors of Contec Medical Systems Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Contec Medical Systems Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Contec Medical Systems Co Ltd generates 0.18x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Contec Medical Systems Co Ltd is currently not profitable relative to its asset base.
Contec Medical Systems Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.63 | 10.68 | 2.46 |
| Quick Ratio | 7.65 | 8.35 | 1.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.10 Billion | CN¥ 1.68 Billion | CN¥ 752.27 Million |
Contec Medical Systems Co Ltd - Advanced Valuation Insights
This section examines the relationship between Contec Medical Systems Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.63 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | -15.1% |
| Total Assets | CN¥2.73 Billion |
| Market Capitalization | $356.65 Million USD |
Valuation Analysis
Below Book Valuation: The market values Contec Medical Systems Co Ltd's assets below their book value (0.13 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Contec Medical Systems Co Ltd's assets decreased by 15.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Contec Medical Systems Co Ltd (2013–2024)
The table below shows the annual total assets of Contec Medical Systems Co Ltd from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.73 Billion | -15.14% |
| 2023-12-31 | CN¥3.21 Billion | -13.95% |
| 2022-12-31 | CN¥3.73 Billion | +33.84% |
| 2021-12-31 | CN¥2.79 Billion | +32.95% |
| 2020-12-31 | CN¥2.10 Billion | +208.87% |
| 2019-12-31 | CN¥679.20 Million | +18.05% |
| 2018-12-31 | CN¥575.37 Million | +3.84% |
| 2017-12-31 | CN¥554.10 Million | +11.95% |
| 2016-12-31 | CN¥494.97 Million | +16.98% |
| 2015-12-31 | CN¥423.14 Million | +39.15% |
| 2014-12-31 | CN¥304.08 Million | +11.37% |
| 2013-12-31 | CN¥273.03 Million | -- |